Macular arteritis in an HIV-infected patient improving with adherence to antiretroviral therapy

by Elisabeth Boddé, MD, Jeffrey Damman, MD, PhD, Martijn B.A. van Doorn, MD, PhD
Published 2020-08-01

Complement Activation in Inflammatory Skin Diseases

by Jenny Giang, Marc A. J. Seelen, Martijn B. A. van Doorn, Robert Rissmann, Errol P. Prens, Jeffrey Damman
Published 2018-04-01

Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review

by Gareth Edwards, Gilles F. H. Diercks, Marc A. J. Seelen, Barbara Horvath, Martijn B. A. van Doorn, Jeffrey Damman
Published 2019-06-01

Bleomycin administered by laser-assisted drug delivery or intradermal needle-injection results in distinct biodistribution patterns in skin: in vivo investigations with mass spectr...

by Kristoffer Hendel, Anders C. N. Hansen, Liora Bik, Charlotte Bagger, Martijn B. A. van Doorn, Christian Janfelt, Uffe H. Olesen, Merete Haedersdal, Catharina M. Lerche
Published 2021-01-01

Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers

by Tessa Niemeyer‐van der Kolk, Salma Assil, Thomas P. Buters, Melanie Rijsbergen, Erica S. Klaassen, Gary Feiss, Edwin Florencia, Errol P. Prens, Jacobus Burggraaf, Martijn B.A. vanDoorn, Robert Rissmann, Matthijs Moerland
Published 2020-05-01

Pharmacodynamic Effects of Topical Omiganan in Patients With Mild to Moderate Atopic Dermatitis in a Randomized, Placebo‐Controlled, Phase II Trial

by Tessa Niemeyer‐van der Kolk, Hein van derWall, Geretta K. Hogendoorn, Rianne Rijneveld, Sascha Luijten, Dirk C.J.G. vanAlewijk, Ellen H.A. van denMunckhof, Marieke L. deKam, Gary L. Feiss, Errol P. Prens, Jacobus Burggraaf, Robert Rissmann, Martijn B.A. vanDoorn
Published 2020-09-01

Inter- and Intra-patient Variability Over Time of Lesional Skin Microbiota in Adult Patients with Atopic Dermatitis

by Ellen H.A. van den Munckhof, Tessa Niemeyer-van der Kolk, Hein van der Wall, Dirk C.J.G. van Alewijk, Martijn B.A. van Doorn, Jacobus Burggraaf, Thomas P. Buters, Martin J. Becker, Gary L. Feiss, Wim G.V. Quint, Leen-Jan van Doorn, Cornelis W. Knetsch, Robert Rissmann
Published 2020-01-01

Initial Results of Secukinumab Drug Survival in Patients with Psoriasis: A Multicentre Daily Practice Cohort Study

by Juul M.P.A. van den Reek, Lieke J. van Vugt, Martijn B.A. van Doorn, Gayle E. van der Kraaij, Wim J.A. de Kort, Georges P.H. Lucker, Barbara Horvath, M. David Njoo, H. Jorn Bovenschen, Paul M. Ossenkoppele, Marjolein S. De Bruin-Weller, Marjan de Groot, Roland Mommers, Ruud L.M.A. Prevoo, Peter C.M. van de Kerkhof, Phyllis I. Spuls, Wietske Kievit, Elke M.G.J. de Jong
Published 2018-04-01

How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study

by Ivan Cherrez-Ojeda, Emanuel Vanegas, Annia Cherrez, Miguel Felix, Karsten Weller, Markus Magerl, Rasmus Robin Maurer, Valeria L. Mata, Alicja Kasperska-Zajac, Agnieszka Sikora, Daria Fomina, Elena Kovalkova, Kiran Godse, Nimmagadda Dheeraj Rao, Maryam Khoshkhui, Sahar Rastgoo, Roberta FJ. Criado, Mohamed Abuzakouk, Deepa Grandon, Martijn B.A. Van Doorn, Solange Oliveira Rodrigues Valle, Eduardo Magalhães De Souza Lima, Simon Francis Thomsen, German D. Ramón, Edgar E. Matos Benavides, Andrea Bauer, Ana M. Giménez-Arnau, Emek Kocatürk, Carole Guillet, Jose Ignacio Larco, Zuo-Tao Zhao, Michael Makris, Carla Ritchie, Paraskevi Xepapadaki, Luis Felipe Ensina, Sofia Cherrez, Marcus Maurer
Published 2021-06-01